Matinas BioPharma Holdings (MTNB) Prepaid Assets (2013 - 2026)
Matinas BioPharma Holdings (MTNB) reported Prepaid Assets of $367000.0 for Q1 2026, down 35.95% year-over-year from $573000.0 in Q1 2025, and up 1311.54% quarter-over-quarter from $26000.0 in Q4 2025.
Matinas BioPharma Holdings (MTNB) Prepaid Assets (2013 - 2026) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 14 years of Prepaid Assets data on file, last reported at $367000.0 in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $367000.0, down 35.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $367000.0 (down 35.95% YoY), and the FY2025 annual result was $26000.0, down 96.24% from the prior year.
- Prepaid Assets grew to $367000.0 in Q1 2026 per MTNB's latest filing, from $26000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $5.7 million in Q4 2022 and troughed at $26000.0 in Q4 2025.
- A 5-year average of $1.7 million and a median of $1.2 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 332.93% in 2022, then plunged 96.24% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $5.7 million in 2022, then sank by 69.63% to $1.7 million in 2023, then plunged by 60.22% to $691000.0 in 2024, then sank by 96.24% to $26000.0 in 2025, then soared by 1311.54% to $367000.0 in 2026.
- Business Quant data shows MTNB's Prepaid Assets at $367000.0 in Q1 2026, $26000.0 in Q4 2025, and $168000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 367,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 693,000.00 |
| Mar 31, 2025 | 573,000.00 |
| Dec 31, 2024 | 691,000.00 |
| Sep 30, 2024 | 896,000.00 |
| Jun 30, 2024 | 922,000.00 |
| Mar 31, 2024 | 2.13 Mn |
| Dec 31, 2023 | 1.74 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 3.30 Mn |
| Dec 31, 2022 | 5.72 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 3.37 Mn |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 2.60 Mn |
| Jun 30, 2021 | 960,422.00 |